MAY 05, 2017 8:28 AM PDT

Study Finds Diabetics Have a Lower Risk of Brain Cancer

WRITTEN BY: Xuan Pham

High blood sugar is a risk factor for diabetes, but for some reason, the elevated sugar levels seem to reduce the risk for brain tumors called meningiomas. The surprising link between the conditions has prompted researchers to reexamine the mechanisms driving brain tumor growth.

Image credit: pixabay.com

"Diabetes and elevated blood sugar increase the risk of cancer at several sites including the colon, breast and bladder. But in this case, these rare malignant brain tumors are more common among people who have normal levels of blood glucose than those with high blood sugar or diabetes," said Judith Schwartzbaum, an associate professor of epidemiology and a researcher in Ohio State's Comprehensive Cancer Center.

Of note, gliomas make up about 27 percent of all brain cancers, which result in 13,000 deaths every year. In particular, the GBM form of glioma is particularly aggressive and notorious for the dismally grim 5-year survival rate of less than 10 percent.

To study the link between blood sugar levels and gliomas, Schwartzbaum and her team analyzed data from two large studies that totaled nearly 798,000 individuals. Of these 812 patients developed the brain tumors. In those patients who had high blood sugar and diabetes, Schwartzbaum found that the risk for glioma was actually lowered.

"This really prompts the question, 'Why is the association between blood glucose levels and brain cancer the opposite of that for several other cancerous tumors?" she said. "Our research raises questions that, when answered, will lead to a better understanding of the mechanisms involved in glioma development.”

The findings are surprising and challenges our basic assumption that cancer cells are glutton for sugar. In fact, some cancer treatments are centered on choking the tumor cells from the body’s glucose supply. But when deprived of one nutrient source, some cancers can still thrive by leeching on other nutrients, like fat, for its survival. Fat-loving cancers include acute myeloid leukemia and prostate cancer – two of the more common cancer types that can’t be starved by cutting the glucose supply.

In that context, perhaps Schwartzbaum’s results hint at glioma’s preference for another nutrient source, or that high glucose is actually dangerous to the tumor.

"This may suggest that the tumor itself affects blood glucose levels or that elevated blood sugar or diabetes may paradoxically be associated with a protective factor that reduces brain tumor risk," Schwartzbaum said. "For example, insulin-like growth factor is associated with glioma recurrence and is found in lower levels in people with diabetes than those who don't have the disease."

As researchers further investigate the mechanism behind this unusual link, they can potentially develop more targeted and effective therapies to squelch the growth of brain tumors.

Additional source: Ohio State University

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 16, 2021
Drug Discovery & Development
Machine Learning Ranks Cancer Drugs by Efficacy
JUL 16, 2021
Machine Learning Ranks Cancer Drugs by Efficacy
A machine learning algorithm developed by researchers at the Queen Mary University of London in the UK can rank cancer d ...
AUG 07, 2021
Cancer
New Drug Combo Eliminates Pancreatic Cancer in Mice
AUG 07, 2021
New Drug Combo Eliminates Pancreatic Cancer in Mice
A combination of three immunotherapy drugs can eliminate pancreatic tumors in mice. The study was published in Canc ...
AUG 24, 2021
Technology
CRISPR Helps Identify New Therapeutic Target for Leukemia
AUG 24, 2021
CRISPR Helps Identify New Therapeutic Target for Leukemia
Researchers may have found a new druggable target in patients with acute myeloid leukemia (AML), thanks to a CRISPR scre ...
SEP 06, 2021
Cancer
A New Biomarker to Personalize Breast Cancer Therapy
SEP 06, 2021
A New Biomarker to Personalize Breast Cancer Therapy
The American Cancer Society estimates that over 280,000 women in the United States will be diagnosed with breast cancer ...
SEP 21, 2021
Drug Discovery & Development
Lifesaving TheraSpheres - glass microbeads can target and destroy colorectal tumors
SEP 21, 2021
Lifesaving TheraSpheres - glass microbeads can target and destroy colorectal tumors
The innovative medical device manufacturer Boston Scientific recently showed success in treating patients with ...
OCT 14, 2021
Clinical & Molecular DX
Weighing Cancer Cells Helps Predict Treatment Outcomes
OCT 14, 2021
Weighing Cancer Cells Helps Predict Treatment Outcomes
Not all cancer patients respond to oncology treatments in the same way. Some might show signs of improvement as the ther ...
Loading Comments...